(Q58375683)
Statements
CYP2C19 Genetic Testing Should Not Be Done in All Patients Treated With Clopidogrel Who Are Undergoing Percutaneous Coronary Intervention (English)
0 references
October 2011
0 references
4
0 references
5
0 references
514-521
0 references